Equillium, Inc. (EQ) vs Korro Bio, Inc. (KRRO)
A side-by-side comparison of Equillium, Inc. and Korro Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EQ
Equillium, Inc.
$1.41HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
KRRO
Korro Bio, Inc.
$9.52HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — EQ vs KRRO
growth of $100 · dividends reinvested · last 7yEQ -60.8% (-12.5%/yr)KRRO -98.5% (-45.4%/yr)EQ compounded faster over this window
Log scale — wide-divergence pair
EQ KRRO
EQ vs KRRO: by the numbers
- •KRRO is the larger company ($95M vs $89M market cap).
- •Both run net losses; EQ's is the smaller (0.00% vs -4477.08% net margin).
Metrics side by side
Valuation
| Metric | EQ | KRRO |
|---|---|---|
| P/S ratio | N/A | 39.78 |
| P/B ratio | 1.59 | 0.92 |
Profitability
| Metric | EQ | KRRO |
|---|---|---|
| Gross margin | 0.00% | 33.04% |
| Operating margin | 0.00% | -1366.43% |
| Net margin | 0.00% | -4477.08% |
| ROE | -32.15% | -103.31% |
| ROIC | -34.10% | -50.17% |
Growth (annualized)
| Metric | EQ | KRRO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -41.67% |
| Total return CAGR (5Y) | -26.99% | -50.72% |
Frequently asked
- How have EQ and KRRO total returns compared?
- Over the past 5 years, EQ delivered -26.99% and KRRO delivered -50.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.